Original equipment manufacturer (OEM) and private labeling services are available for companies developing branded products, providing turnkey solutions from raw material supply through finished dosage form packaging
Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: sodium caprate (C10) and salcaprozate sodium (SNAC)
Compounded tirzepatide may be prescribed as part of a physician-supervised weight management program for individuals who meet specific clinical criteria for treatment
The most common adverse effects primarily affect the central nervous system and include: Dizziness Drowsiness or Sedation Fatigue Ataxia (difficulty with coordination and balance) Peripheral edema (swelling in the hands or feet) Less common but possible side effects include nausea, vomiting, tremor, and blurred vision
The FDA's 2024 and 2025 guidance on compounded GLP-1 medications focused on safety and formulation integrity not on relaxing prescribing standards
[7] [8] This triple-action mechanism distinguishes it from currently approved therapies and is thought to underpin its potentially greater efficacy in weight reduction